The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.164 USD | +3.14% | -13.68% | +18.75% |
The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.235 AUD | -3.52% | -11.79% | 144M | ||
0.164 USD | +3.14% | -13.68% | 27.77M | ||
1st Jan change | Capi. | |
---|---|---|
+18.75% | 27.77M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |